World's Best Scientists 2026 revealed!
Jérôme Galon

Jérôme Galon

Award Badge
Immunology
France
2023
Award Badge
Medicine
France
2023

D-Index & Metrics

Immunology

D-Index
101
Citations
75377
World Ranking
687
National Ranking
22

Medicine

D-Index
102
Citations
75540
World Ranking
7477
National Ranking
232

Research.com Recognitions

  • 2023 - Research.com Immunology in France Leader Award
  • 2023 - Research.com Medicine in France Leader Award
  • 2022 - Research.com Immunology in France Leader Award

Overview

Jérôme Galon is affiliated with Inserm in France and specializes in medicine with a primary focus on oncology. Their research spans several subfields including oncology, immunology, pathology and forensic medicine, cancer research, and surgery. The scientist's work primarily addresses topics related to cancer immunotherapy and biomarkers, colorectal cancer treatments and studies, immunotherapy and immune responses, genetic factors in colorectal cancer, cancer genomics and diagnostics, CAR-T cell therapy research, and colorectal and anal carcinomas.

Their publication record includes significant papers such as:

  • The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy (2020, Nature Reviews. Cancer)
  • Tumor Immunology and Tumor Evolution: Intertwined Histories (2020, Immunity)
  • Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer (2022, Cell)
  • Upfront FOLFOXIRI plus bevacizumab with or without atezolizumab in the treatment of patients with metastatic colorectal cancer (AtezoTRIBE): a multicentre, open-label, randomised, controlled, phase 2 trial (2022, The Lancet Oncology)
  • Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer (2020, Journal of Clinical Oncology)

Jérôme Galon has collaborated frequently with several coauthors, notably:

  • Franck Pagès
  • Bernhard Mlecnik
  • Marc Van den Eynde
  • Florence Marliot
  • Aurélie Catteau

The scientist's publications have appeared consistently in leading journals with a high number of articles published in these venues:

  • Journal of Clinical Oncology (17 publications)
  • OncoImmunology (17 publications)
  • Annals of Oncology (14 publications)
  • Cancers (10 publications)
  • Cancer Research (8 publications)

The research profile of Jérôme Galon is characterized by a consistent attention to cancer immunology and colorectal cancer. Their work encompasses both the biological and clinical aspects of cancer, including the evolving role of immune responses and the development of diagnostic and therapeutic biomarkers.

Best Publications

  • Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

    Jérôme Galon;Anne Costes;Fatima Sanchez-Cabo;Amos Kirilovsky

  • ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks

    Gabriela-Luana Bindea;Bernhard Mlecnik;Hubert Hackl;Pornpimol Charoentong

  • The immune contexture in human tumours: impact on clinical outcome

    Wolf Herman Fridman;Franck Pagès;Catherine Sautès-Fridman;Catherine Sautès-Fridman;Catherine Sautès-Fridman;Jérôme Galon

  • Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer.

    Gabriela Bindea;Bernhard Mlecnik;Bernhard Mlecnik;Bernhard Mlecnik;Marie Tosolini;Marie Tosolini;Marie Tosolini;Amos Kirilovsky;Amos Kirilovsky;Amos Kirilovsky

  • Approaches to treat immune hot, altered and cold tumours with combination immunotherapies

    Jérôme Galon;Daniela Bruni

  • Effector Memory T Cells, Early Metastasis, and Survival in Colorectal Cancer

    Franck Pagès;Anne Berger;Matthieu Camus;Fatima Sanchez-Cabo

  • International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

    Franck Pagès;Bernhard Mlecnik;Florence Marliot;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea

  • GERMLINE MUTATIONS IN THE EXTRACELLULAR DOMAINS OF THE 55 KDA TNF RECEPTOR, TNFR1, DEFINE A FAMILY OF DOMINANTLY INHERITED AUTOINFLAMMATORY SYNDROMES

    Michael F McDermott;Ivona Aksentijevich;Jérôme Galon;Elizabeth M McDermott

  • The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy.

    Daniela Bruni;Helen K Angell;Jérôme Galon

  • Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.

    Jérôme Galon;Jérôme Galon;Jérôme Galon;Bernhard Mlecnik;Bernhard Mlecnik;Bernhard Mlecnik;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea;Helen K. Angell;Helen K. Angell;Helen K. Angell

  • Rethinking ovarian cancer II: Reducing mortality from high-grade serous ovarian cancer

    David D. Bowtell;David D. Bowtell;Steffen Böhm;Ahmed A. Ahmed;Paul Joseph Aspuria

  • Immune infiltration in human tumors: a prognostic factor that should not be ignored.

    Pagès F;Galon J;Galon J;Galon J;Dieu-Nosjean Mc;Dieu-Nosjean Mc;Dieu-Nosjean Mc;Tartour E

  • Clinical Impact of Different Classes of Infiltrating T Cytotoxic and Helper Cells (Th1, Th2, Treg, Th17) in Patients with Colorectal Cancer

    Marie Tosolini;Amos Kirilovsky;Bernhard Mlecnik;Tessa Fredriksen

  • CluePedia Cytoscape plugin

    Gabriela Bindea;Jérôme Galon;Bernhard Mlecnik

  • Histopathologic-Based Prognostic Factors of Colorectal Cancers Are Associated With the State of the Local Immune Reaction

    Bernhard Mlecnik;Marie Tosolini;Amos Kirilovsky;Anne Berger

  • In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer

    Franck Pages;Amos Kirilovsky;Bernhard Mlecnik;Martin Asslaber

  • Integrative Analyses of Colorectal Cancer Show Immunoscore Is a Stronger Predictor of Patient Survival Than Microsatellite Instability

    Bernhard Mlecnik;Bernhard Mlecnik;Bernhard Mlecnik;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea;Helen K. Angell;Pauline Maby

  • Cancer classification using the Immunoscore: a worldwide task force

    Jérôme Galon;Franck Pagès;Francesco M Marincola;Francesco M Marincola;Helen K Angell;Helen K Angell

  • The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures

    Jérôme Galon;Helen K. Angell;Helen K. Angell;Helen K. Angell;Davide Bedognetti;Francesco M. Marincola;Francesco M. Marincola

  • Consensus guidelines for the detection of immunogenic cell death

    Oliver Kepp;Laura Senovilla;Ilio Vitale;Erika Vacchelli

Frequent Co-Authors

Guido Kroemer
Guido Kroemer Université Paris Cité
Laurence Zitvogel
Laurence Zitvogel University of Paris-Saclay
Lorenzo Galluzzi
Lorenzo Galluzzi Cornell University
Alexander M.M. Eggermont
Alexander M.M. Eggermont Institut Gustave Roussy
Bernard A. FoxEarle
Bernard A. FoxEarle Earle A. Chiles Research Institute
Catherine Sautès-Fridman
Catherine Sautès-Fridman Université Paris Cité
Wolf H. Fridman
Wolf H. Fridman Université Paris Cité
Erika Vacchelli
Erika Vacchelli Université Paris Cité
Paolo A. Ascierto
Paolo A. Ascierto National Institutes of Health
Isabelle Cremer
Isabelle Cremer Sorbonne University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, expanding into nursing-related fields offers diverse opportunities. Many students consider programs like accelerated nursing programs to fast-track their entry into the healthcare workforce, gaining essential patient care experience that complements immunological knowledge.

Non-nurses seeking to enter the field can explore the best online RN programs for non nurses. These programs provide a solid foundation in nursing practice, opening doors to specialized roles involving immunology and patient care.

Advanced studies, such as an accelerated nurse practitioner program, further enable individuals to deliver higher-level clinical care and contribute to immunological research and treatment advances.

For current Family Nurse Practitioners (FNPs) aiming to broaden their expertise in critical care related to immunological disorders, understanding the pathway to the fnp to acute care certification is essential. This transition expands career options and deepens clinical impact in immunology-focused settings.

Best Scientists Citing Jérôme Galon

Trending Scientists

Recently Published Articles